Management of peritoneal surface malignancy-Reference-Cited by-同舟云学术

Management of peritoneal surface malignancy

Published:2003-07 Issue:3 Volume:12 Page:xxi-xxiv
ISSN:1055-3207
Container-title:Surgical Oncology Clinics of North America
language:en
Short-container-title:Surgical Oncology Clinics of North America

Author:

Sugarbaker Paul H.

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference6 articles.

1. Hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C significantly improves survival in patients with carcinomatosis of colorectal origin;Zoetmulder;J Clin Oncol ASCO Abstr,2002

2. Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats;Shiu;Cancer Res,1980

3. Hyperthermic peritoneal perfusion system in canines;Spratt;Cancer Res,1980

4. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug;Koga;Cancer Res,1984

5. Pharmacokinetic rationale for peritoneal drug distribution in the treatment of ovarian cancer;Dedrick;Cancer Treat Rep,1978

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Management of Peritoneal Surface Malignancy;Surgical Oncology Clinics of North America;2018-07

2. Peritoneal mesothelioma;British Journal of Hospital Medicine;2010-05

3. Technology of Hyperthermic Intraperitoneal Chemotherapy in the United States, Europe, China, Japan, and Korea;The Cancer Journal;2009-05

4. Carcinomatosis peritoneal. Diez años aplicando la nueva triple terapia combinada. Experiencia personal;Cirugía Española;2007-12

5. REVIEW OF PATIENTS WITH PERITONEAL MALIGNANCY TREATED WITH PERITONECTOMY AND HEATED INTRAPERITONEAL CHEMOTHERAPY;ANZ Journal of Surgery;2006-03